Medical News

RSS

Frisbie Memorial Hospital now uses low-dose CT scanning for screening colorectal cancer

Frisbie Memorial Hospital is now using low-dose CT scanning as a follow-up tool for screening colorectal cancer. This procedure, known as virtual colonoscopy, does not replace the effective and most reliable colorectal cancer screening tool, which is the colonoscopy, but rather it is utilized as a means to obtain additional images of the colon and rectum.

4 Jun 2015

Transwestern named a finalist in 2015 NJBIZ Healthcare Heroes awards program

Transwestern today announces it has been named one of five finalists in the 2015 NJBIZ Healthcare Heroes awards program. Nominated in the "Workplace Wellness Hero" category, Transwestern is being recognized for its company-wide wellness program and efforts to promote a healthy work environment.

4 Jun 2015

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today the enrollment of the first patient in Pivotal's POMEGA Phase IIa clinical trial with PVT-100.

4 Jun 2015

Sexual violence against children significantly higher in low- and middle-income countries

Sexual violence against children is a significant problem in many low- and middle-income countries. At least 25 percent of females and 10 percent of males experienced some form of childhood sexual violence in the majority of seven countries studied, according to findings from the Violence Against Children Surveys (VACS) released today in the Morbidity and Mortality Weekly Report (MMWR) by the Centers for Disease Control and Prevention.

4 Jun 2015

$Elotuzumab boosts response in relapsed, refractory multiple myeloma$

Elotuzumab boosts response in relapsed, refractory multiple myeloma

Addition of the immunostimulatory antibody elotuzumab to the combination of lenalidomide and dexamethasone improves progression-free survival and the overall response rate in patients with relapsed or refractory multiple myeloma, research suggests.

4 Jun 2015

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

The ProGas study results show that three methods of gastrostomy are equally good in terms of complications and survival in patients with amyotrophic lateral sclerosis.

4 Jun 2015

Gender influences nonmotor symptoms in early Parkinson’s

The predominant nonmotor symptoms in patients with Parkinson’s disease vary between men and women, shows an analysis of the Parkinson’s Progression Markers Initiative study.

4 Jun 2015

SCIEX and Metabolon® Launch the Lipidyzer™ Platform for Complete Lipid Analysis, from Sample to Biology

The new Lipidyzer™ Platform enables you to rapidly and accurately differentiate and quantitate over a thousand lipid species, and translates your data into knowledge with ease and efficiency.

4 Jun 2015

Johns Hopkins Medicine recognized for Environmental Sustainability

Johns Hopkins Medicine was recognized for its efforts to reduce its environmental footprint, winning several sustainability awards...

4 Jun 2015

Dexcom® announces follow App is now available for Android devices

Continuous glucose monitoring is considered the most significant breakthrough in diabetes management in the past 40 years...

4 Jun 2015

Two in one to break cycle of poor diabetes management

Now final-year design student Oscar Daws from Brunel University London has come up with a streamlined device which has been selected for a prestigious exhibition on London’s South Bank and aims to vastly improve patients’ self-management of the disease...

4 Jun 2015

AmpliPhi’s bacteriophage manufacturing facility receives cGMP certification

AmpliPhi’s commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...

4 Jun 2015

Epsom and St Helier Hospitals extend use of VitalPAC.

Since August last year nurses on Medical wards at have been recording patient observation data on mobile electronic devices such as iPods using a digital solution called VitalPAC Nurse...

4 Jun 2015

Tabletop design offers greater stability, especially for small laboratory tables

The low-profile, high-density CleanBench tops offer superior damping, stiffness, and flatness in an easy-to-clean stainless steel shell and are available with or without tapped holes...

4 Jun 2015

Questionnaire predicts chances of middle-aged people living until 2020

People aged between 40 and 70 years can now answer a set of simple questions to calculate their personalised 5-year mortality risk and what is referred to as an “Ubble age” – the age where the average mortality risk in the population is most similar to the estimated risk...

4 Jun 2015

WuXi AppTec, Fudan University partner for genomics database system

WuXi AppTec today announced a partnership with Fudan University to bring WuXi NextCODE's world-leading population human genomics database system and integrated research and clinical solutions to the Fudan-led Collaborative Innovation Center of Genetics and Development as an enterprise partner.

4 Jun 2015

RELM Wireless signs agreement with AHS to provide P25 800MHz portable and mobile radios

RELM Wireless Corporation today announced that it has entered into an agreement with Alberta Health Services to provide P25 800MHz portable and mobile radios and accessories. The contract is for a base term of one year that commenced on March 12, 2015, with four one-year options.

4 Jun 2015

Cytokinetics, The ALS Association expand partnership to fight against ALS

Cytokinetics, Incorporated and The ALS Association announced an expanded partnership in which the company will provide Gold Level Sponsorship of the National Walks to Defeat ALS as well as Platinum Level Sponsorship for ALS Association Golden West Chapter initiatives.

4 Jun 2015

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.

4 Jun 2015

Regulus Therapeutics begins RG-012 Phase I clinical study for treatment of Alport syndrome

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21").

4 Jun 2015

Medical News

Frisbie Memorial Hospital now uses low-dose CT scanning for screening colorectal cancer

Transwestern named a finalist in 2015 NJBIZ Healthcare Heroes awards program

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Sexual violence against children significantly higher in low- and middle-income countries

Elotuzumab boosts response in relapsed, refractory multiple myeloma

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

Gender influences nonmotor symptoms in early Parkinson’s

SCIEX and Metabolon® Launch the Lipidyzer™ Platform for Complete Lipid Analysis, from Sample to Biology

Johns Hopkins Medicine recognized for Environmental Sustainability

Dexcom® announces follow App is now available for Android devices

Two in one to break cycle of poor diabetes management

AmpliPhi’s bacteriophage manufacturing facility receives cGMP certification

Epsom and St Helier Hospitals extend use of VitalPAC.

Tabletop design offers greater stability, especially for small laboratory tables

Questionnaire predicts chances of middle-aged people living until 2020

WuXi AppTec, Fudan University partner for genomics database system

RELM Wireless signs agreement with AHS to provide P25 800MHz portable and mobile radios

Cytokinetics, The ALS Association expand partnership to fight against ALS

Rhythm announces initiation of two setmelanotide Phase 2 trials for treatment of PWS, POMC-null obesity

Regulus Therapeutics begins RG-012 Phase I clinical study for treatment of Alport syndrome

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News